Product Information
MORPHINE SULF 100 MG/5 ML CONC is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.3019 per ML under NDC 00054051750. Its NADAC has been published 573 times since Oct 14, 2015.
FDA first approved this application on Mar 17, 2008. Its Orange Book therapeutic-equivalence code is AA.
Strength
100 mg/5mL
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054051750
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MORPHINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA022195FDA Approved
3/17/2008
TE Code
AA
On Market Since
3/17/2008
Pharmacological Classes
Price Statistics
The NADAC for MORPHINE SULF 100 MG/5 ML CONC has been published 573 times since Oct 14, 2015, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3019 per ML |
|---|---|
| All-time high | $0.4623 (Jun 15, 2016) |
| All-time low | $0.2351 (Jun 17, 2020) |
| 52-week high | $0.4117 |
| 52-week low | $0.3019 |
| Median price | $0.3218 |
| Average price | $0.3227 |
| Largest weekly change | +44.7% (Dec 20, 2023) |
| Weeks tracked | 573 |
| Tracking since | Oct 14, 2015 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Morphine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MORPHINE SULF 100 MG/5 ML CONC?
The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULF 100 MG/5 ML CONC, manufactured by Hikma Pharmaceuticals USA Inc., is $0.3019 per ML (NDC 00054051750), effective Sep 30, 2026.
How has the price of MORPHINE SULF 100 MG/5 ML CONC changed over time?
Over the history we have for it, the NADAC for MORPHINE SULF 100 MG/5 ML CONC has declined 17.7%. It has been tracked across 573 weekly CMS publications since Oct 14, 2015.
What are the highest and lowest recorded NADAC prices for MORPHINE SULF 100 MG/5 ML CONC?
Since Oct 14, 2015, the NADAC for MORPHINE SULF 100 MG/5 ML CONC has ranged from a low of $0.2351 (Jun 17, 2020) to a high of $0.4623 (Jun 15, 2016), with a median of $0.3218 per ML.
Are there cheaper alternatives to MORPHINE SULF 100 MG/5 ML CONC?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MORPHINE SULF 100 MG/5 ML CONC in a comparable dosage form, but none are currently priced below it.
Who manufactures MORPHINE SULF 100 MG/5 ML CONC?
MORPHINE SULF 100 MG/5 ML CONC (NDC 00054051750) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.